Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1980 Jun 21;122(12):1381–1386.

Influence of obstetricians' attitudes on their use of prenatal diagnosis for the detection of Down's syndrome.

A Lippman-Hand, D I Cohen
PMCID: PMC1801901  PMID: 6455188

Abstract

Practising obstetricians were surveyed to determine the relation between their referral patterns and their knowledge and attitudes concerning prenatal diagnosis by amniocentesis for women aged 35 years and over. Although 82% had referred at least one eligible patient for prenatal diagnosis during the past year, almost none had used the available services for all appropriate patients. There was a statistically significant trend for increased referral as correct knowledge of the risks and accuracy of prenatal diagnosis increased. Moreover, a discriminant function combining risk and accuracy estimates, type and size of practice, and language distinguished the referrers from the nonreferrers (P = 0.0002), although there was considerable overlap between the physicians classified according to a high, moderate or low rate of referral. The data suggest that while knowledge and practice characteristics can distinguish obstetricians who refer patients for prenatal diagnosis from those who never do so, the frequency of referral may involve other factors, such as how physicians accept innovation and perceive risks.

Full text

PDF
1381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck E., Blaichman S., Scriver C. R., Clow C. L. Advocacy and compliance in genetic screening. Behavior of physicians and clients in a voluntary program of testing for the Tay-Sachs gene. N Engl J Med. 1974 Nov 28;291(22):1166–1170. doi: 10.1056/NEJM197411282912206. [DOI] [PubMed] [Google Scholar]
  2. Childs B., Gordis L., Kaback M. M., Kazazian H. H., Jr Tay-Sachs screening: motives for participating and knowledge of genetics and probability. Am J Hum Genet. 1976 Nov;28(6):537–549. [PMC free article] [PubMed] [Google Scholar]
  3. Etzioni A., Castleman N. Amniocentesis, a forerunner of the genetic fix. Conn Med. 1974 Sep;38(9):487–488. [PubMed] [Google Scholar]
  4. Evans J. A., Hunter A. G., Hamerton J. L. Down syndrome and recent demographic trends in Manitoba. J Med Genet. 1978 Feb;15(1):43–47. doi: 10.1136/jmg.15.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Forster D. P., Davison C. M. Medical care aspects of the prenatal diagnosis of chromosomal abnormalities. Soc Sci Med. 1977 Sep;11(11-13):593–598. doi: 10.1016/0037-7856(77)90040-3. [DOI] [PubMed] [Google Scholar]
  6. Forster D. P. The ante-natal detection of Down's syndrome: some demographic aspects. J Ment Defic Res. 1977 Dec;21(4):263–272. doi: 10.1111/j.1365-2788.1977.tb01589.x. [DOI] [PubMed] [Google Scholar]
  7. Goldstein A. I., Dumars K. W. Minimizing the risk of amniocentesis for prenatal diagnosis. JAMA. 1977 Mar 28;237(13):1336–1338. [PubMed] [Google Scholar]
  8. Hagard S., Carter F. A. Preventing the birth of infants with Down's syndrome: a cost-benefit analysis. Br Med J. 1976 Mar 27;1(6012):753–756. doi: 10.1136/bmj.1.6012.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holmes L. B. Genetic counseling for the older pregnant woman: new data and questions. N Engl J Med. 1978 Jun 22;298(25):1419–1421. doi: 10.1056/NEJM197806222982511. [DOI] [PubMed] [Google Scholar]
  10. Lowry R. B., Jones D. C., Renwick D. H., Trimble B. K. Down syndrome in British Columbia, 1952-73: incidence and mean maternal age. Teratology. 1976 Aug;14(1):29–34. doi: 10.1002/tera.1420140105. [DOI] [PubMed] [Google Scholar]
  11. Miller W. A., Erbe R. W. Prenatal diagnosis of genetic disorders. South Med J. 1978 Feb;71(2):201–206. doi: 10.1097/00007611-197802000-00031. [DOI] [PubMed] [Google Scholar]
  12. Polani E. O. Who's for amniocentesis? Lancet. 1977 May 21;1(8021):1099–1099. doi: 10.1016/s0140-6736(77)92347-9. [DOI] [PubMed] [Google Scholar]
  13. Rothschild H., Ivker F. B. Advocacy and compliance factors in a voluntary selective screening program. South Med J. 1977 Feb;70(2):184–186. doi: 10.1097/00007611-197702000-00023. [DOI] [PubMed] [Google Scholar]
  14. Simpson N. E., Dallaire L., Miller J. R., Siminovich L., Hamerton J. L., Miller J., McKeen C. Prenatal diagnosis of genetic disease in Canada: report of a collaborative study. Can Med Assoc J. 1976 Oct 23;115(8):739–748. [PMC free article] [PubMed] [Google Scholar]
  15. Stein Z., Susser M., Guterman A. V. Screening programme for prevention of Down's syndrome. Lancet. 1973 Feb 10;1(7798):305–310. doi: 10.1016/s0140-6736(73)91551-1. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES